Oscar Health, INC Form 4 insider transactions

Oscar Health's Chief Accounting Officer, Victoria Baltrus, executed multiple transactions involving Class A common stock and restricted stock units, including sales to cover tax obligations.

Thrive Capital, through its affiliated entities, has increased its holdings in Oscar Health by purchasing additional shares of Class A Common Stock.

Joshua Kushner, Co-Founder and Vice Chairman of Oscar Health, has increased his indirect holdings through multiple purchases of Class A Common Stock.

Elbert O. Robinson Jr., a director at Oscar Health, sold 25,000 shares of Class A Common Stock at an average price of $17.05 on November 20, 2024.

Thrive Capital related entities have increased their holdings in Oscar Health through open market purchases of Class A Common Stock.

Joshua Kushner, co-founder and vice chairman of Oscar Health, has increased his indirect holdings in the company through purchases made by Thrive Capital Partners VII Growth, L.P. and Claremount VII Associates, L.P.

Oscar Health director Jeffery H. Boyd exercised stock options to acquire 577,027 shares of Class A Common Stock at $4.29 per share.

Joshua Kushner, Co-Founder and Vice Chairman of Oscar Health, has increased his indirect holdings in the company through multiple purchases of Class A Common Stock between November 11th and November 13th, 2024.

Thrive Capital, through various entities, has significantly increased its holdings in Oscar Health by purchasing shares over three consecutive days.

Director Jeffery H. Boyd acquired 1,802 deferred stock units of Oscar Health, Inc. in lieu of cash retainer payments.

EVP and Chief Insurance Officer of Oscar Health, Alessandrea C. Quane, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Richard Blackley, CFO of Oscar Health, Inc., sold 29,957 shares of Class A Common Stock at an average price of $17.06 on September 6, 2024, following the vesting of 62,500 restricted stock units on September 5, 2024.

Richard Blackley, CFO of Oscar Health, reports the vesting of restricted stock units and subsequent sale of Class A Common Stock.

Mario Schlosser, President of Technology & CTO of Oscar Health, Inc., reports the sale of Class A Common Stock to cover tax obligations related to vesting equity awards.

Ranmali Bopitiya, EVP & Chief Legal Officer of Oscar Health, reports the vesting of restricted stock units and subsequent sale of Class A Common Stock to cover tax obligations.

Steven Wolin, Chief Operating Officer of Oscar Health, Inc., reported the exercise of stock options and subsequent sale of Class A Common Stock to cover tax obligations.

Victoria Baltrus, Chief Accounting Officer of Oscar Health, reported the vesting of restricted stock units and subsequent sales of Class A Common Stock to cover tax obligations.

Alessandrea Quane, EVP and Chief Insurance Officer at Oscar Health, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Jeffrey H. Boyd, a director at Oscar Health, Inc., acquired 1,883 deferred stock units in lieu of cash retainer payments for board service on July 11, 2024.

Director Elbert O. Robinson Jr. acquired 8,974 shares of Oscar Health, Inc. Class A common stock through restricted stock units on June 6, 2024.

Director William Gassen acquired 8,974 shares of Oscar Health's Class A common stock on June 6, 2024, through restricted stock units.

Director David Plouffe acquired 8,974 shares of Oscar Health's Class A common stock on June 6, 2024, through the vesting of restricted stock units.

Vanessa Ames Wittman, a director at Oscar Health, Inc., reported the acquisition of 8,974 restricted stock units (RSUs) on June 6, 2024.

Director Jeffrey Boyd reports the acquisition of 8,974 restricted stock units (RSUs) in Oscar Health, Inc.

Laura Lang, a director at Oscar Health, Inc., reported the acquisition of 8,974 restricted stock units (RSUs) on June 6, 2024.

EVP, Chief Insurance Officer of Oscar Health, Alessandrea C. Quane, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Richard Scott Blackley, CFO of Oscar Health, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Alessandrea Quane, EVP and Chief Insurance Officer at Oscar Health, reports multiple transactions involving Class A Common Stock, including acquisitions through restricted stock unit vesting and sales to cover tax obligations.

Steven Wolin, Chief Operating Officer of Oscar Health, Inc., reported the acquisition and disposition of Class A Common Stock and Restricted Stock Units.

Mario Schlosser, President of Technology & CTO of Oscar Health, Inc., reported the sale of Class A Common Stock to cover tax obligations related to vesting equity awards.